NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-181-2017-0-SG-20 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS SG National Stage 11202002425P Pending
NCI E-181-2017-0-IN-15 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS IN National Stage 202047011647 Pending
NCI E-181-2017-0-CR-11 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CR National Stage 2020-0150 Pending
NCI E-181-2017-0-CA-09 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS CA National Stage 3076339 Pending
NCI E-231-2017-0-PCT-02 IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN PCT PCT PCT/US2018/051418 Expired
NCI E-181-2018-1-US-01 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (Top1) AND TYROSYL-DNA PHOSPHODIESTERASE 1(Tdp1) US 62/732,885 Abandoned
NCI E-237-2017-2-EP-08 T CELL RECEPTORS RECOGNIZING MUTATED P53 EP National Stage 18780006.5 Issued
NCI E-237-2017-2-GB-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 GB EP 18780006.5 Issued
NCI E-237-2017-2-CZ-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 CZ EP 18780006.5 Issued
NCI E-237-2017-2-IT-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 IT EP 18780006.5 Issued
NCI E-237-2017-2-ES-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 ES EP 18780006.5 Issued
NCI E-237-2017-2-TR-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 TR EP 18780006.5 Issued
NCI E-237-2017-2-CH-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 CH EP 18780006.5 Issued
NCI E-237-2017-2-SE-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 SE EP 18780006.5 Issued
NCI E-237-2017-2-DK-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 DK EP 18780006.5 Issued
NCI E-237-2017-2-FI-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 FI EP 18780006.5 Issued
NCI E-237-2017-2-FR-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 FR EP 18780006.5 Issued
NCI E-237-2017-2-IE-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 IE EP 18780006.5 Issued
NCI E-237-2017-2-HU-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 HU EP 18780006.5 Issued
NCI E-237-2017-2-GR-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 GR EP 18780006.5 Issued
NCI E-237-2017-2-DE-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 DE EP 18780006.5 Issued
NCI E-237-2017-2-BE-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 BE EP 18780006.5 Issued
NCI E-237-2017-2-AT-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 AT EP 18780006.5 Issued
NCI E-237-2017-2-PL-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 PL EP 18780006.5 Issued
NCI E-237-2017-2-RO-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 RO EP 18780006.5 Issued
NCI E-237-2017-2-NL-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 NL EP 18780006.5 Issued
NCI E-237-2017-2-PT-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 PT EP 18780006.5 Issued
NCI E-237-2017-2-NO-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 NO EP 18780006.5 Issued
NCI E-237-2017-1-NL-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION NL EP 18782605.2 Issued
NCI E-237-2017-1-CH-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION CH EP 18782605.2 Issued
NCI E-237-2017-1-BE-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION BE EP 18782605.2 Issued
NCI E-237-2017-1-FR-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION FR EP 18782605.2 Issued
NCI E-237-2017-1-IE-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION IE EP 18782605.2 Issued
NCI E-237-2017-1-DE-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION DE EP 18782605.2 Issued
NCI E-237-2017-1-GB-01 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION GB EP 18782605.2 Issued
NCI E-237-2017-1-EP-06 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION EP National Stage 18782605.2 Issued
NCI E-237-2017-2-MX-13 T CELL RECEPTORS RECOGNIZING MUTATED P53 MX National Stage MX/a/2020/003504 Issued
NCI E-237-2017-2-AU-02 T CELL RECEPTORS RECOGNIZING MUTATED P53 AU National Stage 2018342246 Issued
NCI E-237-2017-1-AU-03 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION AU National Stage 2018342245 Issued
NCI E-237-2017-2-CN-05 T CELL RECEPTORS RECOGNIZING MUTATED P53 CN National Stage 201880074539.8 Issued
NCI E-237-2017-2-RU-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 RU EA 202090757 Issued
NCI E-237-2017-2-EA-07 T CELL RECEPTORS RECOGNIZING MUTATED P53 EA National Stage 202090757 Issued
NCI E-237-2017-2-JP-11 T CELL RECEPTORS RECOGNIZING MUTATED P53 JP National Stage 2020-517556 Issued
NCI E-130-2016-0-US-04 ANTI-pY1235-MET IMMUNOLOGICAL BINDING REAGENT US National Stage 16/085,999 1134-02-19 Issued PDF
NIAID E-242-2014-0-US-04 A Monoclonal Antibody Against The N-terminal Portion Of The Circumsporozoite Protein Of Plasmodium Falciparum US CON 16/133,143 10501534 Issued PDF
NCI E-237-2017-2-PCT-01 T CELL RECEPTORS RECOGNIZING MUTATED P53 PCT PCT COMB PCT/US2018/051285 Expired
NCI E-237-2017-1-PCT-02 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION PCT PCT PCT/US2018/051280 Expired
NINDS E-143-2002-1-US-78 METHOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS US CON 16/132,852 Abandoned
NCI E-237-2017-1-CN-05 METHODS OF ISOLATING T CELLS HAVING ANTIGENIC SPECIFICITY FOR A P53 CANCER-SPECIFIC MUTATION CN National Stage 201880063656.4 Pending
NCI E-237-2017-2-CR-06 T CELL RECEPTORS RECOGNIZING MUTATED P53 CR National Stage 2020-0170 Pending